GSK Voluntarily Recalls Paxil in Japan, No Reports of Adverse Reactions

GlaxoSmithKline (GSK) K.K. said on April 7 that it will recall its antidepressant Paxil (paroxetine) from medical institutions in Japan after its British parent received a warning letter from the US FDA last month over quality concerns at an ingredient...read more